Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

FY 2011 International Research

NIAID coordinates and supports collaborative, international research focusing on immunologic and infectious diseases of global health importance.

In fiscal year (FY) 2011, NIAID did the following:

  • Funded 615 international projects totaling approximately $371 million, with 59 percent of funding invested in HIV/AIDS and AIDS-related research.
  • Supported international research activities in 107 countries. The ten foreign countries receiving the largest level of NIAID support were, in order of level of funding: South Africa, Thailand, Uganda, Malawi, Zimbabwe, Canada, United Kingdom, Brazil, Peru, and Australia.
  • Supported more than 400 foreign scientists from 61 countries to train or work in the United States as part of the National Institutes of Health Visiting Scientist Program.
  • Posted full-time staff in China, India, Mali, South Africa, and Uganda.
An international map identifying 107 countries in which NIAID activities were funded in fiscal year 2011. A bar graph depicting NIAID funding for international research in 1980, 2000, and 2011. 
Region Percentage
Sub-Saharan Africa 47.9
Europe 11.6
East Asia/Pacific 18
Americas and the Caribbean 17.2
South/Central Asia 4.8
Middle East and North Africa 0.5
Total 100.0
A pie chart that shows the global distribution of NIAID funding for fiscal year 2011: Sub-Saharan Africa, East Asia/Pacific, Americas and the Caribbean, Europe, South/Central Asia, and the Middle East and North Africa. 

Selected International Meetings

  • Bacterial Waterborne and Emerging Infectious Diseases in North Africa and the Middle East: Opportunities for Collaboration; January 31–February 3, 2011; Nicosia, Cyprus
  • Indo-US NIAID Drug Discovery Forum: Exploring Opportunities for Research Collaboration; April 20–21, 2011; New Delhi, India
  • A Re-Emerging Challenge in the Americas: Opportunities for Dengue Research Collaboration; February 16–18, 2011; San Juan, Puerto Rico

Selected NIAID-Supported International Research Advances

  • Science Magazine’s “Breakthrough of the Year”: An international prevention trial, known as the HIV Prevention Trial Network (HPTN 052), evaluated the effectiveness of two treatment strategies in preventing transmission of the virus from HIV-infected individuals to their uninfected sexual partners. The trial showed that HIV-infected heterosexual individuals who began taking antiretroviral medicines when their immune systems were relatively healthy were 96 percent less likely to transmit the virus to their uninfected partners. The study was conducted at 13 sites in Botswana, Brazil, India, Kenya, Malawi, South Africa, Thailand, the United States, and Zimbabwe.
  • The Pre-Exposure Prophylaxis Initiative (iPrEx) demonstrated that a daily dose of the oral antiretroviral therapy Truvada reduced the risk of acquiring HIV infection by 42 percent among men who have sex with men. The study was conducted at 11 sites in Brazil, Ecuador, Peru, South Africa, Thailand, and the United States.

2011 International Efforts To Support Research Administration

NIAID hosted a series of grants policy workshops around the world for foreign grantees as well as U.S. grantees who have grants with foreign subcomponents.

In FY 2011, NIAID hosted two workshops:

  1. South Africa training—held in Cape Town and included 160 attendees from 12 countries (South Africa, Zimbabwe, Kenya, Botswana, Uganda, Malawi, Zambia, Tanzania, the United States, Nigeria, Ethiopia, and India)
  2. Central America training—held in Panama City and included 37 attendees from eight countries (Argentina, Brazil, Colombia, Guatemala, Haiti, Mexico, Panama, and Peru)

Learn more about NIAID International Research activities​

Last Updated June 15, 2012